-
-
-
-
-
-
-
Corbus names Nishant Saxena as chief business officer
-
-
-
-
-
-
-
Corbus Pharmaceuticals (CRBP) PT Raised to $40 at Mizuho
-
-
-
-
-
-
-
Corbus Pharmaceuticals (CRBP) PT Lowered to $53 at Oppenheimer
-
-
-
-
-
-
-
Corbus Pharmaceuticals (CRBP) PT Lowered to $32 at Mizuho
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Corbus Pharmaceuticals (CRBP)
-
-
-
-
-
-
-
Corbus Pharma (CRBP): FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
-
-
-
-
-
-
-
Corbus Pharmaceuticals (CRBP) PT Lowered to $40 at B.Riley
-
436,054 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

